The human genome harbors large segments that offer no obvious benefit and can potentially even cause disease. Nevertheless, these areas are copied and maintained every time a cell divides, which means a considerable effort and energy cost for the body. What is the evolutionary advantage of preserving these areas? This is the question that virologist and immunologist Prof. Rayk Behrendt from the Cluster of Excellence ImmunoSensation2 at the University of Bonn is addressing. For his research, he now receives the prestigious Consolidator Grant of the European Research Council (ERC). The selected project of the Bonn professor will be funded with about 2 million euros.

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Covid-19 could reduce the success of cancer treatment or cause severe side effects. A recent study by the Universities of Bonn and Shanxi in the People's Republic of China now gives the all-clear in this regard. According to the study, the cancer drugs actually worked better after vaccination with the Chinese vaccine SinoVac than in unvaccinated patients. The results are published as a "Letter to the editor" in the journal Annals of Oncology, but are already available online.

Team NimbRo from the University of Bonn has won the grand prize of five million US dollars at the ANA Avatar XPRIZE competition in Long Beach (USA). The final of the competition, sponsored by the Japanese airline All Nippon Airways (ANA) and hosted by the XPRIZE Foundation, featured 17 teams from ten countries who were selected from 99 registered research groups in a multi-stage qualification process. With a total of ten million US dollars in prize money, the ANA Avatar XPRIZE competition was the most highly endowed robotics competition to date.

Rare gene mutations can significantly increase the risk of severe COVID-19 disease. An international research team with significant contribution of the University of Bonn compared the genetic material of 5,085 people with severe COVID-19 and more than 570,000 controls. The results showed that alterations in the gene TLR7, which is important for the immune defense in humans, lead to infections with a severe course. The findings have now been published in the journal PLOS GENETICS. 

People who strongly identify with their Covid vaccine status discriminate more strongly against the respective other group. This is shown by a study conducted by the team around Luca Henkel, member of the Cluster of Excellence ECONtribute at the University of Bonn, with the participation of the Universities of Erfurt and Vienna and the Bernhard Nocht Institute for Tropical Medicine Hamburg. The study was published in the journal Nature Human Behaviour.

Prof. Lucy O'Brien from University College London receives a research award from the Alexander von Humboldt Foundation. Prof. Dr. Markus Gabriel from the Center for Science and Thought at the University of Bonn nominated the scientist for the award, which is endowed with 60,000 euros. Now both researchers are intensifying their collaboration. The scientist conducts research on the nature of self-consciousness and self-knowledge.

For 35 years now, the Erasmus+ Programme has been helping students achieve their goal of studying abroad. In early summer, the EU Commission allowed universities to draw on unused funds originally intended for German students’ international mobility in order to extend their support to Ukrainian students and university staff in response to Russia’s invasion of Ukraine. The University of Bonn made use of this option and advertised its available places for students from Ukraine in June 2022.

Inflammatory reactions in the skin can reduce damage from UV radiation or infections, but can also result in painful symptoms such as sunburn. A recent study at the University of Bonn and the University Hospital Bonn has now identified a molecular control which integrates these stress signals. The results have been published in the Journal of Experimental Medicine.